We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sensitive Combined Assay Detects Multiple Viruses

By LabMedica International staff writers
Posted on 16 Feb 2012
A combination assay has been developed that identifies several European Arboviruses that cause aseptic meningoencephalitis or febrile disease.

A combined multiplex ligation-dependent probe amplification and flow-through microarray assay was devised for the detection of European Bunyaviruses.

Scientists at the University Medical Center (Göttingen, Germany) decided to try an amplification and hybridization approach, which amplifies a synthetic signal molecule, which is dependent on sequence-specific hybridization rather than an amplification technique that amplifies the target molecule itself. More...
Their methodology combines multiplex ligation-dependent probe amplification (MLPA) with a flow-through chip hybridization system.

The authors developed the assay based on the combination of real time-MLPA (RT-MPLA) and flow-through three-dimensional (3D) universal microarray for the detection of seven European Bunyaviruses, for an expanded accurate diagnosis of aseptic meningoencephalitis and fevers of unknown origin in Europe. The viruses studied were Toscana virus, (TOSV), sand fly fever Sicilian virus (SFSV), sand fly fever Naples virus (SFNV), mosquito-borne Tahyna virus (TAHV), Inkoo virus (INKV), Batai virus (BATV) and tick-borne Uukuniemi virus (UUKV).

Reagents for MLPA and RT-MLPA were obtained from MRC-Holland (Amsterdam, The Netherlands) and the flow-through chip hybridization system was acquired from PamGene ('s-Hertogenbosch, The Netherlands). The sensitivity of MLPA or RT-MLPA flow-through microarray assay ranged from 10 copies for TOSV, INKV, BATV, and UUKV to 1,000 copies for SFSV, SFNV and TAHV. In most cases, the sensitivity of both methods was comparable.

The authors concluded that combined multiplex MLPA and 3D universal microarray assay is sufficiently sensitive and specific for the detection of European Bunyaviruses and show good correlation to monoplex real-time polymerase chain (RT-PCR) assays. The authors expect that this method can be developed into a diagnostic tool for the rapid analysis of infections due to European Arboviruses. The study was published in ther January 2012 issue of Molecular Biotechnology.

Related Links:

University Medical Center
MRC-Holland
PamGene



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.